Epigral Ltd's Q4FY25 Quarter Results
- 06 May 2025
Result Summary
- Epigral Ltd reported a 18.9% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a decline of 7.2%.
- Its expenses for the quarter were down by 16.6% QoQ and 9.5% YoY.
- The net profit decreased 25.4% QoQ and increased 0.7% YoY.
- The earnings per share (EPS) of Epigral Ltd stood at 18.6 during Q4FY25.
Financial Statments for Q4FY25
| (₹ crores) | Q4FY25 | Q3FY25 | Q4FY24 | QoQ (%) | YoY (%) |
|---|---|---|---|---|---|
Total Income | 526.16 | 649.10 | 566.72 | -18.9% | -7.2% |
Total Expenses | 413.31 | 495.57 | 456.63 | -16.6% | -9.5% |
Profit Before Tax | 112.85 | 153.53 | 110.08 | -26.5% | 2.5% |
Tax | 36.18 | 49.99 | 33.33 | -27.6% | 8.6% |
Profit After Tax | 77.28 | 103.63 | 76.73 | -25.4% | 0.7% |
Earnings Per Share | 18.60 | 24.30 | 18.50 | -23.5% | 0.5% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Epigral Ltd is a company whose primary business activities are not directly outlined in the provided data. As such, the core products or services, industry classification, and recent major developments related to Epigral Ltd are not available in this analysis. Typically, such information is crucial for understanding the context of the financial performance but is beyond the scope of this report due to the absence of relevant data. Consequently, the analysis focuses strictly on the financial metrics provided for the fourth quarter of fiscal year 2025 (Q4FY25) compared to previous quarters and the same quarter of the previous year.
Revenue
For the fourth quarter of fiscal year 2025, Epigral Ltd reported total income of ₹526.16 crores. This represents an 18.9% decline in revenue compared to the previous quarter of the same fiscal year (Q3FY25), where the total income was ₹649.10 crores. When compared year-over-year to the fourth quarter of fiscal year 2024, where total income was ₹566.72 crores, there is a decline of 7.2%. These figures suggest significant changes in revenue generation over both the quarter and the year.
Profitability
The profitability metrics of Epigral Ltd for Q4FY25 indicate a profit before tax (PBT) of ₹112.85 crores, which is a decrease of 26.5% from the previous quarter's ₹153.53 crores. There is, however, a slight year-over-year increase of 2.5% from Q4FY24, where the PBT was ₹110.08 crores. The tax paid during Q4FY25 was ₹36.18 crores, which is down 27.6% from ₹49.99 crores in Q3FY25, and up 8.6% from ₹33.33 crores in Q4FY24. The profit after tax (PAT) for Q4FY25 stood at ₹77.28 crores, marking a 25.4% decrease from the previous quarter's ₹103.63 crores, but a marginal increase of 0.7% from the ₹76.73 crores reported in the same quarter of the previous year. The earnings per share (EPS) for Q4FY25 was ₹18.60, compared to ₹24.30 in the previous quarter and ₹18.50 in Q4FY24, reflecting a quarterly decrease of 23.5% and a slight year-over-year increase of 0.5%.
Operating Metrics
Epigral Ltd's total expenses for Q4FY25 were ₹413.31 crores, which shows a decline of 16.6% from the previous quarter's expenses of ₹495.57 crores. On a year-over-year basis, total expenses decreased by 9.5% from ₹456.63 crores in Q4FY24. These changes in expenses align with the variations observed in total income and profitability. The financial data provided does not include specific operating metrics such as production volumes, sales units, or other operational ratios typically used to gauge the operational performance of a company. Therefore, the focus remains on the financial figures that reflect the company's overall expense management and its impact on the profitability metrics.
